Musclin is a novel skeletal muscle-derived factor found in the signal sequence trap of mouse skeletal muscle cDNAs. Recently, it has been demonstrated that musclin is involved in the pathogenesis of spontaneously hypertensive rats (SHRs). However, it is known as a genetic hypertension model. In the present study, we aim to investigate the role of musclin in another animal model of hypertension and characterize the direct effect of musclin on vascular contraction. The results show that expression of musclin was increased in arterial tissues isolated from DOCA-salt induced hypertensive rats or the normal rats received repeated vasoconstriction with phenylephrine. Additionally, direct incubation with phenylephrine did not modify the expression of musclin in the in vitro studies. Also, the direct effect of musclin on the increase of intracellular calcium was observed in a concentration-dependent manner. These results provide the evidence to support that musclin is involved in hypertension. Thus, musclin is suitable to be considered as a novel target for treatment of hypertension.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966495 | PMC |
http://dx.doi.org/10.1155/2014/354348 | DOI Listing |
Acta Biochim Biophys Sin (Shanghai)
December 2024
Department of Cardiovascular Medicine, the General Hospital of Western Theater Command, Chengdu 610083, China.
Exercise ameliorates pulmonary hypertension (PH) progression. However, the underlying mechanisms are largely unclear. Musclin is an exercise-responsive myokine that exerts protective effects on cardiovascular diseases.
View Article and Find Full Text PDFExp Physiol
August 2024
Internal Medicine and Geriatrics, IRCCS INRCA, Ancona, Italy.
J Clin Endocrinol Metab
July 2024
Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine.
Biol Sport
March 2024
Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy.
We considered in this study the possibility of developing an indirect procedure for detecting myostatin inhibition/suppression, a practice that is prohibited as doping in sport. We have specifically considered the potential diagnostic utility of human serum myokines as indirect markers of myostatin inhibition. Myostatin, its main antagonist follistatin, and other myokines (follistatin-like 1, musclin, oncostatin, osteonectin, irisin, brain derived neurotrophic factor, and insulin-like growth factor-1) were selected as a panel of potential biomarkers whose levels may be altered following myostatine suppression.
View Article and Find Full Text PDFCell Stem Cell
February 2024
Department of Pathophysiology, College of High Altitude Military Medicine, Army Medical University, Chongqing 400038, China; Jinfeng Laboratory, Chongqing 401329, China. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!